Johansson, S., Read, J., Oliver, S., Steinberg, M., Li, Y., Lisbon, E., . . . Martin, P. (2014). Pharmacokinetic Evaluations of the Co-Administrations of Vandetanib and Metformin, Digoxin, Midazolam, Omeprazole or Ranitidine. Clinical pharmacokinetics, 53(9), 837-847. https://doi.org/10.1007/s40262-014-0161-2
Chicago Style (17th ed.) CitationJohansson, Susanne, Jessica Read, Stuart Oliver, Mark Steinberg, Yan Li, Eleanor Lisbon, David Mathews, Philip T. Leese, and Paul Martin. "Pharmacokinetic Evaluations of the Co-Administrations of Vandetanib and Metformin, Digoxin, Midazolam, Omeprazole or Ranitidine." Clinical Pharmacokinetics 53, no. 9 (2014): 837-847. https://doi.org/10.1007/s40262-014-0161-2.
MLA (9th ed.) CitationJohansson, Susanne, et al. "Pharmacokinetic Evaluations of the Co-Administrations of Vandetanib and Metformin, Digoxin, Midazolam, Omeprazole or Ranitidine." Clinical Pharmacokinetics, vol. 53, no. 9, 2014, pp. 837-847, https://doi.org/10.1007/s40262-014-0161-2.